Management of Chronic Uremic Pruritus in Hemodialysis Patients
Gabapentin (100-300 mg after each dialysis session, three times weekly) is the most effective medication for treating chronic pruritus due to uremia in hemodialysis patients. 1
First-Line Approach: Optimize Dialysis Parameters
Before initiating pharmacologic therapy, ensure:
- Adequate dialysis (target Kt/V of around 1.6) as pruritus is more common in underdialysed patients 1, 2
- Normalized calcium-phosphate balance and controlled parathyroid hormone levels 1, 2
- Correction of anemia with erythropoietin if present 2
- Regular use of emollients to address xerosis (dry skin), which is the most common cutaneous manifestation in dialysis patients 1, 2
Pharmacologic Treatment Algorithm
First-Line Medication
- Gabapentin 100-300 mg after each dialysis session (three times weekly) 1
- A multicentre, double-blind, placebo-controlled trial showed good response rates with 100 mg postdialysis, with visual analogue ratings falling by over 50% compared to placebo 1
- Note that these are lower doses than used in non-ESRD populations due to reduced renal clearance 1
- Common side effect: mild drowsiness 1
Alternative/Adjunctive Treatments
Topical capsaicin cream (0.025%) applied to affected areas 1, 2
- Acts by depleting neuropeptides including substance P in peripheral sensory neurons 1
Topical calcipotriol for localized areas 1
Doxepin (10 mg twice daily) for short-term use 1
Important Considerations and Pitfalls
Avoid cetirizine (10 mg daily) as it has been shown ineffective specifically for uremic pruritus 1
Avoid long-term sedative antihistamines except in palliative situations, as they may predispose to dementia 1, 2
Ketotifen (1 mg daily) may be as effective as gabapentin according to one RCT, but has less supporting evidence overall 1
Renal transplantation remains the only definitive treatment for uremic pruritus but is not always feasible 1, 3
Pruritus severity monitoring is important as it significantly impacts quality of life and is associated with depression and mortality in hemodialysis patients 4
Despite its high prevalence (affecting 40-90% of hemodialysis patients), uremic pruritus remains underdiagnosed and undertreated, with approximately 17% of severely affected patients not reporting symptoms to healthcare providers 4
Treatment Resistance
For patients with refractory pruritus: